Financial News

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Crispr Therapeutics Ag (NQ: CRSP )

115.74 USD -4.64 (-3.85%)
Official Closing Price Updated: 7:59 PM EDT, Apr 9, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Stories about Crispr Therapeutics Ag

< Previous 1 2 3 4 5 6 7 8 9
...
24 25 Next >
3 Top Biotech Stocks to Buy in June
They have one big thing in common: great growth prospects. 
Tags Market News ICPT CRSP
From Motley Fool
July 24th Options Now Available For CRISPR Therapeutics (CRSP)
Investors in CRISPR Therapeutics AG (CRSP) saw new options become available today, for the July 24th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the CRSP options... 
Tags Stocks
From Market News Video
Better Buy: CRISPR Therapeutics vs. Intellia
Which gene editing stock wins this matchup? 
Tags NVS CRSP Market News
From Motley Fool
Why Editas Medicine Is Now the CRISPR Stock to Really Watch
It could soon be Editas' time to shine. 
Tags EDIT CRSP VRTX
From Motley Fool
These 4 Biotech Stocks Are Outperforming Their Peers — Here's Why
The best biotech companies to invest in tend to have a commonality: a strong streak of earnings growth. 
From Investor's Business Daily
Here's Why Intellia Therapeutics Gained as Much as 18.0% Today
An existing partner is doubling down on the gene editing platform. 
Tags REGN EDIT CRSP
From Motley Fool
July 10th Options Now Available For CRISPR Therapeutics (CRSP)
Investors in CRISPR Therapeutics AG (CRSP) saw new options become available today, for the July 10th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the CRSP options... 
Tags Stocks
From Market News Video
What’s Next For The Biotech Bull Market? Are you a Trader or an Investor?
Despite the economic pains of the pandemic, investors are driven to life science companies in the news with potential solutions for COVID-19. The potential for a COVID-19 vaccine or a new viral... 
Tags Pharma/Biotech Mutual Funds Healthcare
From Blogs - TalkMarkets
Is Vertex Pharmaceuticals Stock a Buy?
This successful biotech has two big things going for it. 
Tags ABBV Market News CRSP
From Motley Fool
How Is COVID-19 Impacting Restaurants?
Our hosts look at some headwinds facing the restaurant industry and how they might survive the pandemic. 
Tags UA NTLA DKNG
From Motley Fool
3 Great Stocks to Buy If You Get a Second Stimulus Check
Uncle Sam could be sending more money your way in the not-too-distant future. Buying these stocks will put the extra cash to good use. 
Tags MA CRSP VRTX
From Motley Fool
Stocks Showing Market Leadership: CRISPR Therapeutics Earns 92 RS Rating
CRISPR Therapeutics shows rising price performance, earning an upgrade to its IBD Relative Strength Rating. 
From Investor's Business Daily
2 Top Gene Editing Stocks to Watch in June
Here's what's behind two of the most exciting stocks in the gene therapy sector. 
Tags FATE VRTX CRSP
From Motley Fool
The Daily Biotech Pulse: NASH Disappointment For Genfit, Novavax Lands $384M CEPI Funding For Coronavirus Vaccine, GW Pharma Earnings
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... 
Tags MRKR REPH LIFE
From Benzinga
CRISPR Therapeutics Shows Rising Price Performance With Jump To 93 RS Rating
A Relative Strength Rating upgrade for CRISPR Therapeutics shows improving technical performance. 
From Investor's Business Daily
Why CRISPR Therapeutics Soared 13.8% Today
One of the company's pipeline candidates received the orphan drug designation from the FDA. 
Tags Market News CRSP
From Motley Fool
How A Gene-Editing Drug Sent This IBD Stock Of The Day To A New High
Vertex Pharmaceuticals is the IBD Stock Of The Day after the biotech company gained a key designation for its gene-editing drug. Now, Vertex stock is forming an add-on entry. 
From Investor's Business Daily
3 Top Biotech Stocks to Buy in May
These hot biotech stocks should be near the top of your list. 
Tags CRSP ABBV Market News
From Motley Fool
3 Reasons to Buy Vertex Pharmaceuticals Stock Right Now
Vertex Pharmaceuticals’ stock has been providing market-beating returns of late. Here’s why it can continue outperforming. 
Tags Market News CRSP VRTX
From Motley Fool
Here's My Top Stock to Buy in May
There are three great reasons to buy this stock sooner rather than later. 
Tags Market News VRTX CRSP
From Motley Fool
Better Buy: Vertex Pharmaceuticals vs. Alexion Pharmaceuticals
Which stock wins in a battle between these two biotechs? 
Tags Market News VRTX ALXN
From Motley Fool
Better Buy: Crispr Therapeutics vs. bluebird bio
Who wins in a matchup between these two gene-editing leaders? 
Tags VRTX CRSP BMS
From Motley Fool
First Week of June 5th Options Trading For CRISPR Therapeutics (CRSP)
Investors in CRISPR Therapeutics AG (CRSP) saw new options begin trading this week, for the June 5th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the CRSP options... 
Tags Stocks
From Market News Video
Another Good Week for Biopharma and Diagnostics Stocks: Innovation is Driving Gains
As the market moves with COVID epidemiological data many stocks took a hit on questionable or incomplete news from the WHO on a clinical study in China on Remdesivir; Gilead Sciences stock took a hit... 
Tags Stocks / Equities Technology ETFs
From Blogs - TalkMarkets
These 3 Biotechs Had Successful IPOs During the Coronavirus Crisis. Are They Buys?
These companies just raised significant cash to advance promising drug pipelines. 
Tags VRTX GBT ZNTL
From Motley Fool
How Banks Have Prepared for Slowdown
One of the byproducts of the Great Recession was giving financial institutions the mindset to come prepared into situations like the present. 
Tags TWTR PINS PG
From Motley Fool
What's The Best Biotech Stock to Buy for Treating Sickle Cell Disease?
Targeted therapies for treating sickle cell disease are finally here after a 60-year wait. 
Tags GBT Market News NVS
From Motley Fool
2 Great Stocks You Can Buy and Hold Forever
These companies -- an online retailer and a biotech -- have plenty of growth drivers. 
Tags Market News AMZN VRTX
From Motley Fool
Have An Extra $1,000? Buy These 2 Biotech Stocks
CRISPR Therapeutics and Exelixis could be excellent long-term picks for your portfolio. 
Tags VRTX CRSP TAK
From Motley Fool
Why Adaptimmune Therapeutics, Atreca, and CRISPR Therapeutics All Tanked In March
These three clinical-stage biotechs are all bargains after last month's marketwide downturn. 
Tags BCEL ADAP CRSP
From Motley Fool
< Previous 1 2 3 4 5 6 7 8 9
...
24 25 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Use the myMotherLode.com Keyword Search to go straight to a specific page

Popular Pages

  • Local News
  • US News
  • Weather
  • State News
  • Events
  • Traffic
  • Sports
  • Dining Guide
  • Real Estate
  • Classifieds
  • Financial News
  • Fire Info
Terms of Service Privacy Policy
© Copyright 2000-2019 Clarke Broadcasting Corporation. All rights reserved.
Feedback